高血圧症の2歳以上6歳未満の小児におけるTAK-536の臨床試験

基本情報

NCT ID

NCT04668157

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

10

治験依頼者名

Takeda

概要

The main aim of this study is to check the safety of TAK-536. This study will take place in Japan. At the first visit, the study doctor will check if each child can take part. For those who can take part, each participant will have a check-up by the study doctor. After this, each participant will take placebo. This might take 2 weeks. After this, parents or the caregivers of each participant will be given sachets that contain granules of TAK-536 to give to that participant. The participants will take the TAK-536 granules once a day for 52 weeks. After treatment has finished, participants will visit the study clinic for a final check-up.

対象疾患

介入

依頼者（Sponsor）

実施施設 (19)